伴随分子生物学的不断进步,许多膀胱肿瘤标志物被逐步发现,因此选择高敏感性和特异性的膀胱肿瘤标志物用于肿瘤的早期诊断和治疗将具有重要的临床应用价值。文章通过对尿液中膀胱肿瘤标志物(存活素、端粒酶、透明质酸、核基质蛋白22及细胞角蛋白)展开探讨,旨在为尿液中膀胱肿瘤标志物的研究进展综述适用提供一些思路。 With the progress of molecular biology, many bladder tumor markers have been gradually discovered, so the selection of high sensitivity and specificity of bladder tumor markers for the early diagnosis and treatment of tumors will have important clinical value. This article explores the urinary bladder tumor markers (survivin, telomerase, hyaluronic acid, nuclear matrix protein 22 and cytokeratin) to investigate the progress of urinary bladder tumor markers. Some ideas.